Na Li

Dr. Na Li

Department of Ophthalmology, the Sixth Medical Center of PLA General Hospital
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in BioMed Research International
Verified
Journal Article
Open access
LGLixiong Gao
Lixiong Gao
WSWeiyang Shao
Weiyang Shao
NLNa Li
Na Li
CTChunyu Tian
Chunyu Tian
HJHongzhen Jia
Hongzhen Jia
QSQian Shi
Qian Shi
Currently, the use of assisted reproductive technology (ART) is increasing. Because of the poor prognosis of retinopathy of prematurity (ROP), the association between ART and the ROP has been explored in several studies, but the result was still inconclusive. Conducting a meta-analysis, we evaluated the risk of ROP in relation to the ART. Subgroup analysis as well as groups with different embryo numbers and different ROP stages was further analyzed. The PubMed, Embase, and Cochrane Library databases were searched for studies recording data about both the use of ART and ROP occurrence simultaneously. Odds ratios (ORs) and 95% confidence interval (95%CI) were calculated to analyze the association by using random- or fixed-effect models based on heterogeneity test. In total 15 observational studies containing 10392 ART cases and 39474 spontaneous conception cases were included. Results showed that there was a significant association between the use of ART and ROP occurrence in the offspring (OR = 1.34, 95% CI: 1.05 to 1.73, P = 0.02). With subgroup analysis, we found that the influence actually came from a subgroup of ART, the in vitro fertilization (IVF). Moreover, there was a significant association between ART and ROP in singletons. Though insignificant, the ORs were larger than 1 in the analysis between ART and stage 1 and 2 ROP. But ART showed significant association with stage 3 ROP. Our study preliminarily indicated that the use of IVF was associated with higher risk of ROP occurrence. And ART is more likely to result in severe ROP and ROP in singletons. Further specific, high-quality studies with large sample size are still needed to draw more precise conclusion.

8 January 2019 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
LGLixiong Gao
Lixiong Gao
LZLijun Zhou
Lijun Zhou
CTChunyu Tian
Chunyu Tian
NLNa Li
Na Li
WSWeiyang Shao
Weiyang Shao
QSQian Shi
Qian Shi
Retinal vein occlusion (RVO) is a common retinal venous disorder that causes vision loss. No specific therapy has been developed. Controversy exists regarding two treatments: intravitreal dexamethasone implants and anti-vascular endothelial growth factor (VEGF). The goal of this study is to compare the effectiveness and safety of dexamethasone implants and anti-VEGF treatment for RVO. The PubMed, Embase, and Cochrane Library databases were searched for studies comparing dexamethasone implants with anti-VEGF in patients with RVO. Best-corrected visual acuity (BCVA), central subfield thickness (CST), intraocular pressure changes, conjunctival haemorrhage, reduced VA, and macular oedema were extracted from the final included studies. RevMan 5.3 was used to conduct the quantitative analysis and bias assessment. Four randomised controlled trials assessing 969 eyes were included. The anti-VEGF treatment showed better BCVA improvement (mean difference [MD] = − 10.59, P < 0.00001) and more CST decrease (MD = − 86.71 μm, P = 0.02) than the dexamethasone implants. However, the dexamethasone implants required fewer injections. As for adverse effects, the dexamethasone implants showed significantly higher intraocular pressure (IOP) and more cataracts than the anti-VEGF treatment. No significant differences were found in conjunctival haemorrhage, reduced VA, and macular oedema. Anti-VEGF treatment showed better functional and anatomical improvement with less risk of IOP elevation and cataract formation compared to dexamethasone implants. Thus, anti-VEGF treatment is the first choice for treating RVO patients.

22 July 2021 in Chinese Medical Journal
Verified
Journal Article
Open access
NLNa Li
Na Li
ZFZhengjun Fan
Zhengjun Fan
XPXiujun Peng
Xiujun Peng
An abstract is unavailable. This article is available as a PDF only.

16 February 2024 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
NLNa Li
Na Li
ZFZhengjun Fan
Zhengjun Fan
XPXiujun Peng
Xiujun Peng

15 February 2023 in Asia-Pacific Journal of Oncology Nursing
Verified
Journal Article
Open access
XLXin Li
Xin Li
NLNa Li
Na Li
YLYuhan Lu
Yuhan Lu
XMXiaoxiao Ma
Xiaoxiao Ma
HYHong Yang
Hong Yang
FCFan Chen
Fan Chen
[This corrects the article DOI: 10.1016/j.apjon.2021.12.005.].